Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: Evidence from in vivo and in vitro modulation of cell signalling

Journal of Physiology

Volumn 591, Issue 12, 2013, Pages 2999-3015

  Galougahi, Keyvan Karimi ^a,b   Liu, Chia Chi ^a   Garcia, Alvaro ^a   Fry, Natasha A S ^a   Hamilton, Elisha J ^a   Rasmussen, Helge H ^a,b   Figtree, Gemma A ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR; CELL PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; METOPROLOL; P22PHOX PROTEIN; P47PHOX PROTEIN; PROTEIN KINASE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; HEART FUNCTION; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; RABBIT; SIGNAL TRANSDUCTION;

ACTION POTENTIALS; ADENYLATE CYCLASE; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; COLFORSIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUTAREDOXINS; MALE; METOPROLOL; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATION-REDUCTION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN SUBUNITS; RABBITS; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84879264417     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.252817     Document Type: Article

References (54)

1. 3-Adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 440, 99-107.
2. 3 adrenoceptors. Br J Pharmacol 160, 1048-1061.
3. Bers DM (2005). Phospholemman-phosphorylation mediates the β-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 97, 252-259.
4. Bers DM & Despa S (2009). Na/K-ATPase-an integral player in the adrenergic fight-or-flight response. Trends Cardiovasc Med 19, 111-118.
5. 1 subunit. J Biol Chem 286, 18562-18572.
6. Bristow MR (2011). Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology. Circ Res 109, 1176-1194.
7. + pump. Am J Physiol Cell Physiol 281, C1059-C1063.
8. +. Am J Physiol Cell Physiol 277, C461-C468.
9. + pump sites in cardiac myocytes. Am J Physiol Cell Physiol 286, C398-C405.
10. + pump by reversal of an inhibitory oxidative modification. Circulation 122, 2699-2708.
11. Despa S, Bossuyt J, Han F, Ginsburg KS, Jia LG, Kutchai H, Tucker AL & Bers DM (2005). Phospholemman-phosphorylation mediates the β-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 97, 252-259.
12. + pump rate in rat and rabbit ventricular myocytes. J Physiol 539, 133-143.
13. - channels by protein kinases A and C. Pflugers Arch 444, 251-262.
14. + pump regulation. Circ Res 105, 185-193.
15. Francis SH, Busch JL, Corbin JD & Sibley D (2010). cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62, 525-563.
16. Fry NA, Garcia A, Karimi K, McLachlan C, Liu CC, Figtree GA & Rasmussen HH (2012). Circulation 126, A16252.
17. Fuller W, Tulloch LB, Shattock MJ, Calaghan SC, Howie J & Wypijewski KJ (2013). Regulation of the cardiac sodium pump. Cell Mol Life Sci 70, 1357-1380.
18. Gadsby DC, Kimura J & Noma A (1985). Voltage dependence of Na/K pump current in isolated heart cells. Nature 315, 63-65.
19. Gadsby DC, Nagel G & Hwang TC (1995). The CFTR chloride channel of mammalian heart. Annu Rev Physiol 57, 387-416.
20. Gadsby DC & Nakao M (1989). Steady-state current-voltage relationship of the Na/K pump in guinea pig ventricular myocytes. J Gen Physiol 94, 511-537.
21. Gallogly MM, Starke DW & Mieyal JJ (2009). Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal 11, 1059-1081.
22. + ATPase mediated by oxidative signalling. Trends Cardiovasc Med 22, 83-87.
23. + pump in guinea-pig ventricular myocytes. J Physiol 449, 689-704.
24. + pump current-voltage relationship in guinea-pig ventricular myocytes. J Physiol 494, 697-708.
25. Geering K (2006). FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol 290, F241-F250.
26. + pump function in rabbit ventricular myocytes. Am J Physiol Cell Physiol 292, C1070-C1077.
27. + pump via effects on angiotensin metabolism. Am J Physiol Cell Physiol 271, C172-C180.
28. + pumping in cardiac myocytes. Am J Physiol Cell Physiol 268, C366-C375.
29. 1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways. Cardiovasc Res 53, 355-362.
30. Ke HY, Collins TP, Rowlands C & MacLeod KT (2012). A decrease in Na/K ATPase function occurs before changes to calcium handling in a guinea-pig model of progressive heart failure. Circulation 126, A16055.
31. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM & Casadei B (2005). A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97, 629-636.
32. Levi AJ, Lee CO & Brooksby P (1994). Properties of the fluorescent sodium indicator "SBFI" in rat and rabbit cardiac myocytes. J Cardiovasc Electrophysiol 5, 241-257.
33. Li, JM & Shah AM (2003). Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 278, 12094-12100.
34. 2 formation. Free Radic Biol Med 42, 1465-1469.
35. + pump subunit to glutathionylation and oxidative inhibition depends on conformational state of pump. J Biol Chem 287, 12353-12364.
36. Lizotte E, Tremblay A, Allen BG & Fiset C (2005). Isolation and characterization of subcellular protein fractions from mouse heart. Anal Biochem 345, 47-54.
37. + pump. Circ Res 86, 37-42.
38. Mishra NK, Peleg Y, Cirri E, Belogus T, Lifshitz Y, Voelker DR, Apell H-J, Garty H & Karlish SJD (2011). FXYD proteins stabilize Na, K-ATPase: amplification of specific phosphatidylserine-protein interactions. J Biol Chem 286, 9699-9712.
39. O'Hara T & Rudy Y (2012). Quantitative comparison of cardiac ventricular myocyte electrophysiology and response to drugs in human and nonhuman species. Am J Physiol Heart Circ Physiol 302, H1023-H1030.
40. Pastore A & Piemonte F (2012). S-Glutathionylation signaling in cell biology: Progress and prospects. Eur J Pharm Sci 46, 279-292.
41. i handling in the failing human heart. Cardiovasc Res 57, 874-886.
42. Pogwizd SM, Sipido KR, Verdonck F & Bers DM (2003). Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis. Cardiovasc Res 57, 887-896.
43. +-binding site in molecular dynamics simulations. J Biol Chem 287, 15959-15965.
44. Rasmussen HH, Liu C, Hamilton EJ & Figtree GA (2010). Reversible oxidative modification: implications for cardiovascular physiology and pathophysiology. Trends Cardiovasc Med 20, 85-90.
45. Sanchez G, Escobar M, Pedrozo Z, Macho P, Domenech R, Hartel S, Hidalgo C & Donoso P (2008). Exercise and tachycardia increase NADPH oxidase and ryanodine receptor-2 activity: possible role in cardioprotection. Cardiovasc Res 77, 380-386.
46. Shah AM & Mann DL (2011). In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378, 704-712.
47. Shen YT, Cervoni P, Claus T & Vatner ST (1996). Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J Pharmacol Exp Ther 278, 1435-1443.
48. Sweadner KJ & Rael E (2000). The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68, 41-56.
49. Townsend DM, Manevich Y, He L, Hutchens S, Pazoles CJ & Tew KD (2009). Novel role for glutathione S-transferase π. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284, 436-445.
50. + pump and inhibits its activity. J Biol Chem 285, 13712-13720.
51. + pump in isolated rabbit cardiac myocytes. J Physiol 565, 815-825.
52. Xiang YK (2011). Compartmentalization of β-adrenergic signals in cardiomyocytes. Circ Res 109, 231-244.
53. Zhang M & Kass DA (2011). Phosphodiesterases and cardiac cGMP: evolving roles and controversies. Trends Pharmacol Sci 32, 360-365.
54. Zhao H, Joseph J, Fales HM, Sokoloski EA, Levine RL, Vasquez-Vivar J & Kalyanaraman B (2005). Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc Natl Acad Sci U S A 102, 5727-5732.